CNS Clinical Research
Accelerating CNS drug development using innovative biomarkers and product
Healthcare
Providing evidence-based digital health solutions to revolutionise treatment approaches within mental health
Accelerating CNS drug development using innovative biomarkers and product
Providing evidence-based digital health solutions to revolutionise treatment approaches within mental health
P1vital Products Ltd are pleased to announce that the RTOC clinical study has been able to re-open recruitment across all 4 recruiting sites (based in the Netherlands, Germany, Spain and Greece) with new procedures in place to minimize risk of disease transmission.
Following successful data collection for the P1vital Cognitive Evaluation (VICOG) study, P1vital Products Ltd has donated £500 to Alzheimer’s Research UK. Dementia is a devastating disease which manifests itself through memory loss, mood changes and problems with communication, attention and thinking, amongst other symptoms. In the UK, it affects over 850,000 people, and costs the… Read more »